Artes Medical, Inc.

April 03, 2006 09:14 ET

Artes Medical Names Diane Goostree President and Chief Operating Officer

SAN DIEGO--(CCNMatthews - Apr 3, 2006) -

Medical Technology Company Appoints Esteemed Business Executive to Senior Management Team to Prepare for Launch of First Product

Artes Medical, Inc., a fully-integrated medical technology company focused on the development, manufacture and commercialization of a new category of permanent aesthetic injectable products, today announced the appointment of Diane S. Goostree to President and Chief Operating Officer.

As President and COO, Goostree will lead sales and marketing, manufacturing, engineering, finance and regulatory affairs and quality for Artes Medical. Goostree will report to Artes Medical's Founder & CEO, Dr. Stefan Lemperle. The management addition comes at an exciting time for the Company as FDA approval for its lead product ArteFill®, the first permanent aesthetic injectable for the correction of facial wrinkles known as nasolabial folds or smile lines, is pending.

"Diane Goostree is a well-accomplished pharmaceutical and medical industry executive who has a proven track record in business operations. We look forward to the wealth of knowledge and relevant industry experience she brings to Artes Medical, which will help us in our transition from a clinical development and manufacturing to a sales and marketing driven company," said Dr. Stefan Lemperle, CEO of Artes Medical. "Her extensive business development background and thorough knowledge of the industry makes her a well-suited fit to strengthen Artes Medical. I'm looking forward to closely working with Diane who shares our passion and commitment in establishing a new category of permanent injectable aesthetic products for consumers."

Ms. Goostree has over 20 years experience in both the public and private pharmaceutical industry. Prior to Artes, Ms. Goostree served as the Senior Vice President, Corporate Development and Operations, for SkinMedica, Inc., a dermatology specialty pharmaceutical company, where she managed a number of departments including manufacturing, business development, strategic planning and various marketing functions, and served a leading role in building the company. Ms. Goostree has also held senior positions at Elan Pharmaceuticals, Dura Pharmaceuticals and Sanofi Aventis (previously Marion/Merrell Dow).

"Artes Medical has given me a tremendous opportunity to join this extremely innovative and entrepreneurial company at a very exciting time," said Ms. Goostree. "I am looking forward to collaborating with Stefan Lemperle and working closely with the talented executive management team at Artes to help execute on the rare opportunity of launching an original class III medical device, which requires FDA approval for its pre-market approval application."

Ms. Goostree holds a Master of Business Administration degree from the University of Missouri and a Bachelor of Science (Chemical Engineering) from the University of Kansas.

About Artes Medical, Inc.

Artes Medical is a fully-integrated medical technology company focused on the development, manufacture and commercialization of a new category of injectable aesthetic products for the dermatology and plastic surgery markets. The Company's lead product candidate is ArteFill, a permanent aesthetic injectable, for the treatment of facial wrinkles known as nasolabial folds or smile lines. ArteFill is based on the Company's proprietary platform technology, from which other products may be developed.

ArteFill consists of a unique combination of Precision-Filtered Microspheres™ suspended in a carrier gel containing Purified Bovine Collagen™ and 0.3 percent lidocaine. The microspheres are made of polymethylmethacrylate (PMMA), the most commonly used artificial implant material used in the human body. The microspheres act as a support matrix for enduring wrinkle correction. Since the microspheres are permanent, the result is expected to be long-lasting. ArteFill's pre-market approval application (PMA) has been deemed approvable by the FDA. Once ArteFill receives final approval, it will be the first and only FDA-approved permanent injectable implant for the treatment of facial wrinkles known as smile lines or nasolabial folds.

Based in San Diego, Calif., Artes Medical was founded in 1999 and is privately-held. Additional information about the Company and its products are available at Artes Medical and ArteFill, are registered trademarks of Artes Medical, Inc.

Contact Information